Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine

BACKGROUND: Type 2 diabetes causes cardio-renal complications and is treated with different combination therapies. The renal hemodynamics profile of such combination therapies has not been evaluated in detail. METHODS: Patients (N = 97) with type 2 diabetes were randomized to receive either empaglif...

Descripción completa

Detalles Bibliográficos
Autores principales: Ott, Christian, Jung, Susanne, Korn, Manuel, Kannenkeril, Dennis, Bosch, Agnes, Kolwelter, Julie, Striepe, Kristina, Bramlage, Peter, Schiffer, Mario, Schmieder, Roland E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418746/
https://www.ncbi.nlm.nih.gov/pubmed/34481498
http://dx.doi.org/10.1186/s12933-021-01358-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418746/
https://www.ncbi.nlm.nih.gov/pubmed/34481498
http://dx.doi.org/10.1186/s12933-021-01358-8

Ejemplares similares